Entyvio 108 MG/0.68 ML pen 0.68ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM7B6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,547
Award facts
- Contract value 100% obligated
- $15,547.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,547.32 to AmerisourceBergen Drug Corp for the supply of Entyvio 108 mg/0.68 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical products will be delivered to the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. Entyvio is a specialized biologic medication used in the treatment of inflammatory bowel disease, reflecting the scope of specialty pharmaceuticals AmerisourceBergen supplies through its federal contracts.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Department of Defense and military healthcare systems. The company's comprehensive IDC vehicle enables it to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military personnel worldwide. As one of the primary vendors in DLA's pharmaceutical supply chain, AmerisourceBergen continues to compete for individual delivery orders while maintaining its substantial blanket purchase agreement capacity to meet evolving federal healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FM7B6?
SPE2DR26FM7B6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FM7B6 worth?
The government has obligated $15,547 on SPE2DR26FM7B6.
Is contract SPE2DR26FM7B6 an order under another contract?
Yes. SPE2DR26FM7B6 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM7B6 competed?
The extent of competition for SPE2DR26FM7B6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award